NewsBenzinga아드바크 테라퓨틱스, 프래더-윌리 증후군 치료제 데이터 불충분하다고 밝혀 아드바크 테라퓨틱스, 프래더-윌리 증후군 치료제 데이터 불충분하다고 밝혀 Benzinga 2026.10.23 15:43 (GMT+0) Open on Benzinga Other news EXCLUSIVE: Ryan Detrick Isn’t Worried About Midterm Election Outcome – ‘Focus on the Fundamentals’ DA Davidson Maintains Neutral on RideNow Group, Lowers Price Target to $5 Nvidia China Trouble Could Spill Over to These AI Chip Stocks Wall Street Looks Beyond US Stocks: Morgan Stanley’s Europe Call Puts These ETFs on the Radar Fed's Hammack Says Businesses Are Passing On More Price Increases; Says Job Market Has Been Largely In Balance, But Is Not Dynamic Citigroup Maintains Buy on Nebius Group, Lowers Price Target to $215
Fed's Hammack Says Businesses Are Passing On More Price Increases; Says Job Market Has Been Largely In Balance, But Is Not Dynamic